The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings

BACKGROUND: The SafeBoosC phase II randomised clinical trial recently demonstrated the benefits of a combination of cerebral regional tissue oxygen saturation (rStO(2)) by near-infrared spectroscopy (NIRS) and a treatment guideline to reduce the oxygen imbalance in extremely preterm infants. AIMS: T...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Arch Dis Child Fetal Neonatal Ed
Auteurs principaux: Riera, Joan, Hyttel-Sorensen, Simon, Bravo, María Carmen, Cabañas, Fernando, López-Ortego, Paloma, Sanchez, Laura, Ybarra, Marta, Dempsey, Eugene, Greisen, Gorm, Austin, Topun, Claris, Olivier, Fumagalli, Monica, Gluud, Christian, Lemmers, Petra, Pichler, Gerhard, Plomgaard, Anne Mette, van Bel, Frank, Wolf, Martin, Pellicer, Adelina
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2016
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941140/
https://ncbi.nlm.nih.gov/pubmed/26645538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/archdischild-2015-308829
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires